Main phone
  • Boston University, Ph.D., Biochemistry
  • McGill University, B.S. Biochemistry
Danielle N. Gross, Ph.D.
Professional Experience

Danielle is a patent agent and focuses her practice on patent preparation and prosecution for domestic and foreign clients. She also provides comprehensive patentability and freedom to operate opinions, as well as manages patent portfolios for clients across multiple jurisdictions.

Danielle has experience across a range of technologies including pharmaceuticals, biotechnology, organic chemistry, inorganic chemistry, small molecules, nucleic acids, proteins, peptides, molecular diagnostics, and medical devices, where she uses her technical experience to strategically advise clients. Danielle has also gained valuable knowledge in the mechanical arts having represented a large multinational automotive corporation over the past number of years.

Previous Work

Prior to joining Volpe and Koenig, Danielle worked as a medical writer where she prepared research manuscripts, review articles, congress abstracts, and presentations on a variety of therapeutics and medical devices under various stages of clinical development. She was also involved with publication planning, drafting scientific statements, and gap analyses for pharmaceutical industry clients.

Danielle has extensive experience as a research scientist. Her doctoral work focused on vesicle trafficking and transport of glucose into cells, as well as the regulation of catecholamine-induced lipolysis. Following graduate school, Danielle did a post-doctoral fellowship at the University of Pennsylvania where she studies the effects of cytokine signaling on pancreatic beta-cells using transgenic mouse models. As a scientist, she co-authored numerous scientific publications, was awarded research grants, and presented her work at major scientific meetings.

Bar and Court Admissions

U.S. Patent and Trademark Office



Publications, Presentations and Recognitions

Substantial Evidence that New Methods of Treatment Relying on Old Drugs may be Patentable (October 11, 2019); Bucklin, DJ and Gross, DN;

Two Steps Forward Then Big Steps Back – Pharma’s Patent Rights at Risk (January 18, 2017); Gross, DN;

You Are Unreasonable (March 4, 2016); Gross, DN and Bucklin DJ;

USPTO New Proposed Information Disclosure Framework (November 23, 2015); Bucklin DJ and Gross, DN;

Life Beyond the Law

I am a Pilates and Yoga enthusiast, and love to hike, kayak, bike, and ski whenever I get the chance. My other interests include the symphony, the ballet, playing the piano, travelling, and spending time with my family and friends.